NCCN Guidelines

LEXINGTON, MASSACHUSETTS, USA, April 14, 2026 Partner Therapeutics, Inc. has announced the submission of a supplemental Biologics License Application...

Queensbury, New York, USA, April 6, 2026 ESMO Guideline Inclusion Validates CHEMOSAT Therapy In a major milestone for interventional...

DUBLIN, Oct. 2, 2025 – Jazz Pharmaceuticals plc (Nasdaq: JAZZ) announced today that the U.S. Food and Drug Administration...